The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 09, 2016

Filed:

Jul. 28, 2015
Applicant:

Washington University, Saint Louis, MO (US);

Inventor:

Rajendra S. Apte, Clayton, MO (US);

Assignee:

Washington University, Saint Louis, MO (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/47 (2006.01); A61K 31/265 (2006.01); A61K 9/00 (2006.01); A61K 31/421 (2006.01); A61K 31/18 (2006.01); A61K 31/195 (2006.01); A61K 31/4706 (2006.01); A61K 31/575 (2006.01); A61K 31/58 (2006.01); A61K 38/17 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
A61K 31/47 (2013.01); A61K 9/0048 (2013.01); A61K 9/0053 (2013.01); A61K 31/18 (2013.01); A61K 31/195 (2013.01); A61K 31/265 (2013.01); A61K 31/421 (2013.01); A61K 31/4706 (2013.01); A61K 31/575 (2013.01); A61K 31/58 (2013.01); A61K 38/1709 (2013.01); C12N 15/113 (2013.01);
Abstract

Methods of treatment of diseases that include or are characterized by inappropriate or pathological neovascularization are disclosed. These diseases include diseases of the eye, such as diabetic retinopathy, retinopathy of prematurity, and choroidal neovascularization which can occur in age-related macular degeneration (AMD). Disclosed methods include administering agents that cause directly or indirectly upregulation of the ABCA1 transporter protein in macrophages. These agents include, without limitation, LXR agonists. In some embodiments, inhibitors of CETP expression or activity can also be effective. Administration routes can include, without limitation, intraocular, periocular, or systemic administration.


Find Patent Forward Citations

Loading…